Letter to the Editor
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. May 27, 2024; 16(5): 1482-1484
Published online May 27, 2024. doi: 10.4240/wjgs.v16.i5.1482
Exploring predictive markers for liver failure post-hepatectomy in hepatocellular carcinoma patients
Shi-Yan Zhang, Xiong-Jian Ma, Xue-Xia Zhu, Na Cai
Shi-Yan Zhang, Xiong-Jian Ma, Xue-Xia Zhu, Na Cai, Department of Clinical Laboratory, Fuding Hospital, Fujian University of Traditional Chinese Medicine, Fuding 355200, Fujian Province, China
Author contributions: Zhang SY and Ma XJ designed and performed research; Zhu XX wrote the comment; and Cai N revised the comment. All the authors listed have read and approved the final manuscript.
Conflict-of-interest statement: The authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Shi-Yan Zhang, MD, Director, Doctor, Department of Clinical Laboratory, Fuding Hospital, Fujian University of Traditional Chinese Medicine, No. 120 South Road of Old City, Fuding 355200, Fujian Province, China. myebox@139.com
Received: February 1, 2024
Revised: April 9, 2024
Accepted: April 17, 2024
Published online: May 27, 2024
Processing time: 112 Days and 7 Hours
Core Tip

Core Tip: Acknowledges the study's comprehensive analysis and its contribution to hepatocellular carcinoma management. These findings suggest further exploration of the clinical applicability of the neutrophil-lymphocyte ratio, fibrosis index based on four factors, and aspartate aminotransferase-to-platelet ratio index in diverse patient groups. Prospective studies for the validation of these findings are recommended. This highlights the importance of considering the confounding factors in future research.